Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Joseph, James A.; * | Neuman, Anna | Bielinski, Donna F. | Fisher, Derek R.
Affiliations: USDA-HNRCA, Tufts University, Boston, MA, USA
Correspondence: [*] Corresponding author: J.A. Joseph, Ph.D., USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington St., Boston, MA 02111, USA. Tel.: +1 617 556 3178; Fax: +1 617 556 3222; E-mail: james.joseph@ars.usda.gov.
Abstract: Research indicates that muscarinic receptors (MAChRs) may show selective declines in sensitivity during aging and Alzheimer's disease (AD), and these decrements may be related to oxidative stress sensitivity. M1AChR – transfected COS-7 cells exhibit greater decrements in Ca2+ buffering following oxotremorine-induced depolarization than M3 cells. This loss, induced via dopamine (DA) or amyloid-β (Aβ), is similar to those reported in many studies with respect to aging and AD, but were antagonized by blueberry (BB) treatment. However, they may be exacerbated by ceramide which shows considerable increases in AD and aging. Thus, the effects of DA, Aβ42 and/or BB were assessed on calcium parameters (e.g., calcium buffering) in the presence or absence of ceramide in M1 and M3 transfected cells. Results indicated that while ceramide did not produce profound deficits in calcium buffering, in either M1- or M3-transfected COS-7 cells, decrements were seen in the ability of M1- and M3-transfected cells to initially respond to oxotremorine, regardless of DA or Aβ42 exposure. BB pre-treatment (prior to ceramide) antagonized the ceramide treatment in M1-transfected cells but not M3-transfected cells, where ceramide suppressed BB effects. Results are discussed in terms of the effects on lipid induced changes in plasma membranes.
Keywords: Aging, blueberry polyphenols, ceramide, muscarinic receptors, oxidative stress
DOI: 10.3233/JAD-2008-15309
Journal: Journal of Alzheimer's Disease, vol. 15, no. 3, pp. 429-441, 2008
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl